Mapping the STK4/Hippo signaling network in prostate cancer cell

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Dysregulation of the MST1/STK4 kinase, a core component of the Hippo-YAP pathway, is implicated in aggressive cancers with poor prognoses.
• The precise mechanisms by which STK4 inhibits aggressive cancer development are not fully understood.

Purpose of the Study:

• To investigate the impact of STK4 localization (cytoplasmic, lipid raft, nuclear) on cell growth and gene expression in aggressive prostate cancer.
• To elucidate how STK4's subcellular positioning influences its tumor-suppressive functions.

Main Methods:

• Utilized RNA sequencing and bioinformatics analysis to identify differentially expressed genes in response to ectopic STK4 expression across different cellular compartments.
• Conducted in vitro and in vivo experiments to assess the effects of STK4 on aggressive prostate cancer cell growth.

Main Results:

• Lipid raft and nuclear STK4 exhibited significantly greater suppressive effects on cell growth compared to cytoplasmic STK4.
• Ectopic STK4 influenced gene expression across all three compartments, with lipid raft and nuclear localization affecting a larger number of genes.
• Differentially expressed genes were associated with key oncogenic pathways including AR, PI3K/AKT, BMP/SMAD, GPCR, WNT, and RAS. Nuclear STK4 uniquely modulated the JAK/STAT pathway.

Conclusions:

• MST1/STK4/Hippo signaling acts as a crucial suppressor of aggressive tumor cell proliferation by interacting with diverse molecular pathways.
• Targeting the STK4/Hippo pathway holds potential therapeutic implications for managing aggressive cancers.